| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62135-977-90 | 62135-977 | HUMAN PRESCRIPTION DRUG | IRBESARTAN | IRBESARTAN | TABLET | ORAL | 20250501 | N/A | ANDA | ANDA077205 | Chartwell RX, LLC | IRBESARTAN | 150 mg/1 | 90 TABLET in 1 BOTTLE (62135-977-90) |
| 62135-978-30 | 62135-978 | HUMAN PRESCRIPTION DRUG | IRBESARTAN | IRBESARTAN | TABLET | ORAL | 20250506 | N/A | ANDA | ANDA077205 | Chartwell RX, LLC | IRBESARTAN | 300 mg/1 | 30 TABLET in 1 BOTTLE (62135-978-30) |
| 62135-978-90 | 62135-978 | HUMAN PRESCRIPTION DRUG | IRBESARTAN | IRBESARTAN | TABLET | ORAL | 20250501 | N/A | ANDA | ANDA077205 | Chartwell RX, LLC | IRBESARTAN | 300 mg/1 | 90 TABLET in 1 BOTTLE (62135-978-90) |
| 62135-977-30 | 62135-977 | HUMAN PRESCRIPTION DRUG | IRBESARTAN | IRBESARTAN | TABLET | ORAL | 20250506 | N/A | ANDA | ANDA077205 | Chartwell RX, LLC | IRBESARTAN | 150 mg/1 | 30 TABLET in 1 BOTTLE (62135-977-30) |
| 62135-976-90 | 62135-976 | HUMAN PRESCRIPTION DRUG | IRBESARTAN | IRBESARTAN | TABLET | ORAL | 20250501 | N/A | ANDA | ANDA077205 | Chartwell RX, LLC | IRBESARTAN | 75 mg/1 | 90 TABLET in 1 BOTTLE (62135-976-90) |
| 62135-976-30 | 62135-976 | HUMAN PRESCRIPTION DRUG | IRBESARTAN | IRBESARTAN | TABLET | ORAL | 20250506 | N/A | ANDA | ANDA077205 | Chartwell RX, LLC | IRBESARTAN | 75 mg/1 | 30 TABLET in 1 BOTTLE (62135-976-30) |